Siddhartha Yadav, MD, MBBS | Authors

Input From a Multidisciplinary Team of Medical Providers is ‘Necessary’ to Manage Contralateral Breast Cancer, Says Expert

January 06, 2023

It takes a team of physicians from multidisciplinary backgrounds to best manage patients with contralateral breast cancer, according to a Mayo Clinic Expert.

Physicians Should Factor Race, Ethnicity and Much More When Making Treatment Decisions in Contralateral Breast Cancer, Says Expert

January 03, 2023

The presence of several risk factors—such as age, race and mutation status—for contralateral breast cancer must be considered when making treatment decisions, according to an expert from the Mayo Clinic.

New Study Findings Will Generate Better Contralateral Breast Cancer Treatment Discussions Between Providers and Patients, Says Expert

January 02, 2023

Recent study findings related to risk factors for developing contralateral breast cancer may better influence treatment decisions between patients and physicians, according to a Mayo Clinic expert.

Carriers of CHEK2 Mutations Have a 2-Fold Increased Risk for Contralateral Breast Cancer, Says Expert

January 01, 2023

An expert from the Mayo Clinic discusses findings from a population-based study concerning germline genetic mutations as risk factors of contralateral breast cancer.

Many Unanswered Questions About Risks for Contralateral Breast Cancer Led to CARRIERS Study, Says Expert

December 30, 2022

An expert from the Mayo Clinic explains why he and his colleagues are researching risk factors for contralateral breast cancer in carriers of moderate-risk genes such as ATM, CHEK2, and PALB2.

Oncology Peer Review On-The-Go: Experts Share Multidisciplinary Takeaways From 2022 SABCS

December 26, 2022

Judy C. Boughey, MD; Robert Mutter, MD; and Siddhartha Yadav, MD, MBBS, of Mayo Clinic spoke with CancerNetwork® multidisciplinary findings presented at the 2022 San Antonio Breast Cancer Symposium, ranging from surgery to radiotherapy to biomarker research.